New toolkit aims to take the guesswork out of mammograms for women over 80

NCT ID NCT07123649

Recruiting now Knowledge-focused Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a decision-making toolkit for women aged 80 and older who have had breast cancer. The toolkit provides clear information to help them and their doctors decide whether to continue yearly mammograms. Researchers will track how many mammograms participants get over two years and whether the toolkit improves their understanding of the risks and benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Shared Decision-Making Toolkit
What this could lead to: If successful, this toolkit could help older breast cancer survivors make more informed, personalized decisions about whether to continue routine mammograms.
What could go wrong: This is a relatively small, early-phase study focused on decision-making, not on survival or cancer outcomes. The toolkit may not change actual mammography rates or improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Dana-Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.